INTERINDIVIDUAL AND INTRAINDIVIDUAL VARIABILITY IN ACETYLATION - CHARACTERIZATION WITH CAFFEINE

被引：27

作者：

HARDY, BG

LEMIEUX, C

WALKER, SE

BARTLE, WR

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1988年 / 44卷 / 02期

关键词：

D O I：

10.1038/clpt.1988.130

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：152 / 157

页数：6

相关论文

共 24 条

[1] KINETIC DISCRIMINATION OF 3 SULFAMETHAZINE ACETYLATION PHENOTYPES
CHAPRON, DJ
KRAMER, PA
MERCIK, SA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) : 104 - 113
[2] ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE
DAS, KM
EASTWOOD, MA
MCMANUS, JPA
SIRCUS, W
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (10) : 491 - 495
[3] EVANS DAP, 1964, J LAB CLIN MED, V63, P394
[4] VARIABILITY IN CAFFEINE METABOLISM
GRANT, DM
TANG, BK
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (05) : 591 - 602
[5] A SIMPLE TEST FOR ACETYLATOR PHENOTYPE USING CAFFEINE
GRANT, DM
TANG, BK
KALOW, W
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (04) : 459 - 464
[6] POLYMORPHIC N-ACETYLATION OF A CAFFEINE METABOLITE
GRANT, DM
TANG, BK
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) : 355 - 359
[7] LOWER GM, 1982, CANCER-AM CANCER SOC, V49, P1056, DOI 10.1002/1097-0142(19820301)49:5<1056::AID-CNCR2820490535>3.0.CO
[8] 2-I
[9] DISEASE AND ACETYLATION POLYMORPHISM
LUNDE, PKM
FRISLID, K
HANSTEEN, V
[J]. CLINICAL PHARMACOKINETICS, 1977, 2 (03) : 182 - 197
[10] OLSEN H, 1982, ACTA PHARMACOL TOX, V50, P67